418 related articles for article (PubMed ID: 28815906)
1. Deep gray matter iron measurement in patients with liver cirrhosis using quantitative susceptibility mapping: Relationship with pallidal T
Lee S; Nam Y; Jang J; Na GH; Kim DG; Shin NY; Choi HS; Jung SL; Ahn KJ; Kim BS
J Magn Reson Imaging; 2018 May; 47(5):1342-1349. PubMed ID: 28815906
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study.
Ning N; Liu C; Wu P; Hu Y; Zhang W; Zhang L; Li M; Gho SM; Kim DH; Guo H; Yang J; Jin C
J Magn Reson Imaging; 2019 Jun; 49(6):1600-1609. PubMed ID: 30569483
[TBL] [Abstract][Full Text] [Related]
3. Increased iron deposition of deep cerebral gray matter structures in hemodialysis patients: A longitudinal study using quantitative susceptibility mapping.
Chai C; Wang H; Liu S; Chu ZQ; Li J; Qian T; Haacke EM; Xia S; Shen W
J Magn Reson Imaging; 2019 Mar; 49(3):786-799. PubMed ID: 30291651
[TBL] [Abstract][Full Text] [Related]
4. STrategically Acquired Gradient Echo (STAGE) imaging, part I: Creating enhanced T1 contrast and standardized susceptibility weighted imaging and quantitative susceptibility mapping.
Chen Y; Liu S; Wang Y; Kang Y; Haacke EM
Magn Reson Imaging; 2018 Feb; 46():130-139. PubMed ID: 29056394
[TBL] [Abstract][Full Text] [Related]
5. Human brain atlas for automated region of interest selection in quantitative susceptibility mapping: application to determine iron content in deep gray matter structures.
Lim IA; Faria AV; Li X; Hsu JT; Airan RD; Mori S; van Zijl PC
Neuroimage; 2013 Nov; 82():449-69. PubMed ID: 23769915
[TBL] [Abstract][Full Text] [Related]
6. Multi-atlas tool for automated segmentation of brain gray matter nuclei and quantification of their magnetic susceptibility.
Li X; Chen L; Kutten K; Ceritoglu C; Li Y; Kang N; Hsu JT; Qiao Y; Wei H; Liu C; Miller MI; Mori S; Yousem DM; van Zijl PCM; Faria AV
Neuroimage; 2019 May; 191():337-349. PubMed ID: 30738207
[TBL] [Abstract][Full Text] [Related]
7. Assessing global and regional iron content in deep gray matter as a function of age using susceptibility mapping.
Liu M; Liu S; Ghassaban K; Zheng W; Dicicco D; Miao Y; Habib C; Jazmati T; Haacke EM
J Magn Reson Imaging; 2016 Jul; 44(1):59-71. PubMed ID: 26695834
[TBL] [Abstract][Full Text] [Related]
8. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity.
Klos KJ; Ahlskog JE; Kumar N; Cambern S; Butz J; Burritt M; Fealey RD; Cowl CT; Parisi JE; Josephs KA
Neurology; 2006 Dec; 67(11):1984-9. PubMed ID: 17159105
[TBL] [Abstract][Full Text] [Related]
9. Importance of extended spatial coverage for quantitative susceptibility mapping of iron-rich deep gray matter.
Elkady AM; Sun H; Wilman AH
Magn Reson Imaging; 2016 May; 34(4):574-8. PubMed ID: 26721523
[TBL] [Abstract][Full Text] [Related]
10. MR susceptibility contrast imaging using a 2D simultaneous multi-slice gradient-echo sequence at 7T.
Bian W; Kerr AB; Tranvinh E; Parivash S; Zahneisen B; Han MH; Lock CB; Goubran M; Zhu K; Rutt BK; Zeineh MM
PLoS One; 2019; 14(7):e0219705. PubMed ID: 31314813
[TBL] [Abstract][Full Text] [Related]
11. Iron and manganese homeostasis in chronic liver disease: relationship to pallidal T1-weighted magnetic resonance signal hyperintensity.
Malecki EA; Devenyi AG; Barron TF; Mosher TJ; Eslinger P; Flaherty-Craig CV; Rossaro L
Neurotoxicology; 1999 Aug; 20(4):647-52. PubMed ID: 10499363
[TBL] [Abstract][Full Text] [Related]
12. Age-dependent changes in brain iron deposition and volume in deep gray matter nuclei using quantitative susceptibility mapping.
Li G; Tong R; Zhang M; Gillen KM; Jiang W; Du Y; Wang Y; Li J
Neuroimage; 2023 Apr; 269():119923. PubMed ID: 36739101
[TBL] [Abstract][Full Text] [Related]
13. Progressive iron accumulation across multiple sclerosis phenotypes revealed by sparse classification of deep gray matter.
Elkady AM; Cobzas D; Sun H; Blevins G; Wilman AH
J Magn Reson Imaging; 2017 Nov; 46(5):1464-1473. PubMed ID: 28301067
[TBL] [Abstract][Full Text] [Related]
14. Quantitative susceptibility mapping (QSM) minimizes interference from cellular pathology in R2* estimation of liver iron concentration.
Li J; Lin H; Liu T; Zhang Z; Prince MR; Gillen K; Yan X; Song Q; Hua T; Zhao X; Zhang M; Zhao Y; Li G; Tang G; Yang G; Brittenham GM; Wang Y
J Magn Reson Imaging; 2018 Oct; 48(4):1069-1079. PubMed ID: 29566449
[TBL] [Abstract][Full Text] [Related]
15. On the value of QSM from MPRAGE for segmenting and quantifying iron-rich deep gray matter.
Naji N; Sun H; Wilman AH
Magn Reson Med; 2020 Sep; 84(3):1486-1500. PubMed ID: 32125012
[TBL] [Abstract][Full Text] [Related]
16. MRI pallidal signal in children exposed to manganese in drinking water.
Dion LA; Bouchard MF; Sauvé S; Barbeau B; Tucholka A; Major P; Gilbert G; Mergler D; Saint-Amour D
Neurotoxicology; 2016 Mar; 53():124-131. PubMed ID: 26801245
[TBL] [Abstract][Full Text] [Related]
17. Deep grey matter iron accumulation in alcohol use disorder.
Juhás M; Sun H; Brown MRG; MacKay MB; Mann KF; Sommer WH; Wilman AH; Dursun SM; Greenshaw AJ
Neuroimage; 2017 Mar; 148():115-122. PubMed ID: 28065850
[TBL] [Abstract][Full Text] [Related]
18. Quantitative Susceptibility Mapping in Parkinson's Disease.
Langkammer C; Pirpamer L; Seiler S; Deistung A; Schweser F; Franthal S; Homayoon N; Katschnig-Winter P; Koegl-Wallner M; Pendl T; Stoegerer EM; Wenzel K; Fazekas F; Ropele S; Reichenbach JR; Schmidt R; Schwingenschuh P
PLoS One; 2016; 11(9):e0162460. PubMed ID: 27598250
[TBL] [Abstract][Full Text] [Related]
19. Switching from linear to macrocyclic gadolinium-based contrast agents halts the relative T
Rowe SK; Rodriguez D; Cohen E; Grundy R; Morgan PS; Jaspan T; Dineen RA
J Magn Reson Imaging; 2020 Jan; 51(1):288-295. PubMed ID: 31165554
[TBL] [Abstract][Full Text] [Related]
20. Quantitative Susceptibility Mapping of Amyloid-β Aggregates in Alzheimer's Disease with 7T MR.
Tiepolt S; Schäfer A; Rullmann M; Roggenhofer E; ; Gertz HJ; Schroeter ML; Patt M; Bazin PL; Jochimsen TH; Turner R; Sabri O; Barthel H
J Alzheimers Dis; 2018; 64(2):393-404. PubMed ID: 29865069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
